Home›Search›Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy

Walter de Gruyter GmbH · Germany · Est. 2010

ISSN2363-8907

SJR Q2✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.322

H-Indexi

SNIPi

0.32

Total Worksi

433

Total Citationsi

2,902

2yr Mean Citednessi

2.00

Open Impact Factor alternative

Aims & Scope

Subject areas: Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacology (medical).

General Information

Country / RegionGermany

Primary Language—

1st Year Published2010

Annual Volume~ 32 articles / year

StatusActive (last: 2026)

Total Publications433

Publisher OrgDe Gruyter

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Walter de Gruyter GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2363-8907

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

641

2019

195

2020

341

2021

156

2022

145

2023

136

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q2

Pharmacology (medical)Q3

Subject Classification

Scopus Categories

Pharmacology (medical)Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsPhytochemicals and Medicinal PlantsPharmaceutical studies and practicesEicosanoids and Hypertension PharmacologyAcute Lymphoblastic Leukemia researchPharmacological Effects and Toxicity StudiesAntiplatelet Therapy and Cardiovascular DiseasesPharmacological Effects of Medicinal PlantsComputational Drug Discovery Methods

Frequently asked questions about Drug Metabolism and Personalized Therapy

Is Drug Metabolism and Personalized Therapy a predatory journal?

PubScope has no integrity flags on record for Drug Metabolism and Personalized Therapy: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Drug Metabolism and Personalized Therapy?

Drug Metabolism and Personalized Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.322.

Is Drug Metabolism and Personalized Therapy indexed in Scopus and Web of Science?

Drug Metabolism and Personalized Therapy is indexed in Scopus.

What is the aims and scope of Drug Metabolism and Personalized Therapy?